Eli Lilly to Buy 3 Vaccine Developers
Eli Lilly has a long history in infectious diseases.
Related Stories
Wall Street Braces for SpaceX With Stress Test, ‘Watch Parties’
Wall Street Braces for SpaceX With Stress Test, ‘Watch Parties’ Wall Street has spent months debating how much SpaceX is worth. Behind the scenes, a different challenge has occupied the institutions responsible for bringing it public: preparing the plumbing systems needed to support what could become the largest IPO in history. S&P Global Inc.’s Equity Bookbuild group, which helps underwriters capture and allocate investor demand during initial public offerings, has spent weeks expanding the...
NASA names crew for Artemis III lunar lander rehearsal
NASA has named the four astronauts set to fly the Artemis III mission in an announcement that raised as many questions as it answered. The quartet is comprised of a Space Shuttle veteran, Randy Bresnik, as commander, and the European Space Agency's Luca Parmitano, whose helmet filled with water during an International Space Station (ISS) spacewalk. NASA astronauts Frank Rubio and Andre Douglas will serve as mission specialists.
Weight-loss drug users save over £400 a year on grocery bills as take-up triples
New research suggests GLP-1 users are buying fewer snacks and treats such as crisps and chocolateBusiness live – latest updatesWeight-loss drugs are saving users’ households more than £400 a year on grocery bills, according to new research, which found use of GLP-1s has nearly tripled in the past two years to 1.9 million adults. Just more than 6.3% of households in Great Britain now include at least one GLP-1 user, according to the survey from Worldpanel by Numerator. This marks a sharp rise...
Weight loss drug users save over £400 on food as take-up triples
Research suggests households that include a GLP-1 user collectively spent £780m less on grocery billsBusiness live – latest updatesWeight-loss drugs are saving users’ households more than £400 a year on grocery bills, according to a survey, which found use of GLP-1s has nearly tripled in the past two years to 1.9 million adults. More than 6.3% of households in Great Britain now include at least one GLP-1 user, according to the research by Worldpanel by Numerator. This marks a sharp rise from...